Radiotherapy for newly diagnosed adult high grade gliomas in the Asia Pacific Region.

J Clin NeurosciMay 28, 2026 (epub)

A Chua, E Brillante, N Cupino et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined radiotherapy protocols for newly diagnosed adult high grade gliomas (HGG) in the Asia Pacific region. It found that treatment protocols largely align with EANO and NCCN guidelines, though access to these treatments varies by country. The study highlights the need for a national patient database to better understand real-world application and barriers to access.

Key findings

  • Radiotherapy protocols for HGG in the Asia Pacific region closely follow EANO and NCCN guidelines.
  • There is variability in the application of these protocols across different income-level countries.
  • Identified barriers to radiotherapy access need to be addressed for improved patient outcomes.

Why it matters

Understanding the adherence to established guidelines and the barriers to treatment access is crucial for improving patient outcomes in high grade gliomas. This knowledge can inform policy and resource allocation in the region.

Source

Published in J Clin Neurosci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.